Myeloablative radiochemotherapy and hematopoietic stem-cell rescue in poor-prognosis Ewing's sarcoma

Journal of Clinical Oncology

Volumn 11, Issue 8, 1993, Pages 1482-1488

  Burdach, S ^a   Jurgens H ^a   Peters, C ^a   Nurnberger W ^a   Mauz Korholz C ^a   Korholz D ^a   Paulussen, M ^a   Pape, H ^a   Dilloo, D ^a   Koscielniak, E ^a   Gadner, H ^a   Gobel U ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; MELPHALAN;

ADOLESCENT; ADULT; ARTICLE; BONE GRAFT; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; EWING SARCOMA; HUMAN; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; RECURRENCE RISK; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE NEOPLASMS; CARBOPLATIN; CHILD; COHORT STUDIES; COMBINED MODALITY THERAPY; CYTOKINES; ETOPOSIDE; FEASIBILITY STUDIES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MELPHALAN; PROGNOSIS; RECURRENCE; REMISSION INDUCTION; SARCOMA, EWING'S; SUPPORT, NON-U.S. GOV'T; SURVIVAL ANALYSIS; WHOLE-BODY IRRADIATION;

EID: 0027183531     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1993.11.8.1482     Document Type: Article

References (20)

1. Jürgens H, Bier V, Dunst J, et al: Die GPO eooperativen Ewing-Surkom Studien CESS 81/86: Berieht nach 61/2 Jahren, The GPO cooperative Kwing sarcoma studies CESS 81/86: A report alter 61/2 years). Klin Padiatr 200:243-252, 1988
2. Jürgens H, Exner U, Kühl J, et al: Multidisciplinary treatment of primary Ewing sarcoma of hone. A 6-year experience of a European Cooperative Trial. Cancer 61:23-32, 1988
3. Paulussen M, Braun-Munzinger G, Burdach S, et al: Behand Lungsergehnisse beim ausehließlich pulmonal primár metastasierten Ewingsarkom. (Treatment results in Ewing's sarcoma with pulmonary metastasis at diagnosis.) Klin Pädiatr (in press)
4. Huckels ML: Therapiemoglichkeiten für Patienten mit primär metastasiertem Ewing-Sarkom: Eine Analyse der nach der Cooperativen Ewing-Sarkom-Studie CESS 81 behandelten Patienten, (treatment of Ewing sarcoma with primary metastases: An analysis of the CESS-81 study). Doctoral thesis. Heinrich-Heine-Universität. Düsseldorf, Germany, 1991
5. Wessalowski R, Jürgens H, Bodenstein H, et al: Behandlungsergehnisse heim primär metastasierten Ewing-Sarkom: Eine retrospektive Analyse von 48 Patienten. (Treatment results in stage IV Ewing sarcoma: A retrospective analysis of 48 patients.) Klin Pädiatr 200:253-260, 1988
6. Kinsella TJ, Miser JS, Waller B, et al: Long-term follow-up of Ewing's sarcoma of hone treated with combined modality therapy. Int J Radiat Oneol Biol Phys 20:389-395, 1991
7. Kinsella TJ, Glaubiger D, Diesseroth A, et al: Intensive combined modality therapy including low-dose TBI in high-risk Ewing's sarcoma patients. Int J Radial Oncol Biol Phys 9:1955-1960, 1983
8. Miser J: Autologous bone marrow transplantation for the treatment of sarcomas, in Johnson FL, Pochedly C (eds): Bone Marrow Transplantation in Children. New York, NY, 1990. pp 289-298
9. Corableet MA, Corringham RET, Prentice GH, et al: Treatment of Ewing's sarcoma with high-dose melphalan and autologous hone marrow transplantation. Cancer Treat Rep 65:241-244, 1981
10. Hartmann O, Oberlin O, Beaujean F, et al: Place de la chimiothérapie à hautes doses suivie d'autogreffe medullaire dans le traitement des sarcomes d'Ewing métastatiques de l'enfant. Bull Cancer (Paris) 77:181-187, 1990
11. Kinsella TJ, Mitchell JB, McPherson S, et al: In vitro radiation studies on Ewing's sarcoma cell lines and human bone marrow: Application to the clinical use of total body irradiation (TBI). Int J Radial Oncol Biol Phys 10:1005-1011, 1984
12. Evans RG, Burgert O, Gilchrist GS, et al: Sequential half-body irradiation (SHBI) and combination chemotherapy as salvage treatment for failed Ewing's sarcoma - A pilot study. Int J Radiat Oncol Biol Phys 10:2363-2368, 1984
13. Burdach S, Peters C, Paulusscn M, et al: Improved prognosis for patients with primary multifocal or early relapsing Ewing sarcoma after consolidation with hyperfractionated total body irradiation and fractionated high dose melphalan followed by high dose etoposide and hematopoietic stem cell transplantation. Med Pediatr Oncol 19: 399, 1991 (abstr 230)
14. Burdach S, Peters C, Paulussen M, et al: Improved relapse free survival in patients with poor prognosis Ewing's sarcoma after consolidation with hyperfractionated total body irradiation and fractionated high dose melphalan followed by high dose etoposide and hematopoietic rescue. Bone Marrow Transplant 7:95, 1991 (abstr: suppl 2)
15. 5. Emminger W, Emminger-Schmidmeier W, Hawliczek R, et al: High-dose melphalan, etoposide ± carboplatin (MEC) combined with 12-gray fractionated total-body irradiation in children with generalized solid tumors. Pediatr Hematol Oncol 8:13-22, 1991
16. Schmidt D, Harms D, Burdach S: Malignant peripheral neuroectodermal tumours of childhood and adolescence. Virchows Arch [A] 406:351-365, 1985
17. Schmidt D, Herrmann C, Jürgens H, et al: Malignant peripheral neuroeclodermal tumor - Its necessary distinction from Ewing's sarcoma. Cancer 68:2251-2259, 1991
18. Hartman KR, Triche TJ, Kinsella TJ, et al: Prognostic value of histopathology in Ewing's sarcoma: Long-term follow-up of distal extremity primary tumors. Cancer 67:163-171, 1991
19. Cangir A, Teresa JV, Edmund A, et al: Ewing's sarcoma metastatic at diagnosis: Results and comparisons of two intergroup Ewing's sarcoma studies. Cancer 66:887-893, 1990
20. Ladenstein R, Lasset C, Biron J, et al: The impact of megatherapy on response and survival in high-risk Ewing's sarcoma. A report of the EBMT solid tumor registry. Bone Marrow Transplant 10:20, 1992 (abstr; suppl 2)